Relief for Sun Pharma: SEBI finds no merit in allegations of fraud

CNBC-TV18 2019-08-29

Views 130

Sun Pharmaceuticals will be in focus today as reports suggests Securities and Exchange Board of India (SEBI) finds no merit in allegations of fraud against the company. Sonia Shenoy has more details.

Share This Video


Download

  
Report form